重續持續關連交易

 

	樂普心泰醫療科技（上海）股份有限公司 (02291)

► Entrusted Products Related Framework Agreement ► Letter from the Independent Board Committee ► Letter from the Independent Financial Adviser ► Written Consent of the Expert